Fig. 3.

a Summary of modified RECIST version 1.0 (mRECIST) response. All responses were confirmed by week 18. Disease control rate is the sum of patients with confirmed partial response or stable disease at week 12. b Best change from baseline in investigator-assessed measurements of soft-tissue lesions using mRECIST was determined for patients who had baseline and at least one post-baseline radiographic scan in the first 12 weeks (n = 39). ^aConfirmed partial response. RECIST, Response Evaluation Criteria in Solid Tumors